237 related articles for article (PubMed ID: 34087381)
21. Saracatinib, a Src Tyrosine Kinase Inhibitor, as a Disease Modifier in the Rat DFP Model: Sex Differences, Neurobehavior, Gliosis, Neurodegeneration, and Nitro-Oxidative Stress.
Gage M; Putra M; Wachter L; Dishman K; Gard M; Gomez-Estrada C; Thippeswamy T
Antioxidants (Basel); 2021 Dec; 11(1):. PubMed ID: 35052568
[TBL] [Abstract][Full Text] [Related]
22. Selective inhibition of mTORC1/2 or PI3K/mTORC1/2 signaling does not prevent or modify epilepsy in the intrahippocampal kainate mouse model.
Gericke B; Brandt C; Theilmann W; Welzel L; Schidlitzki A; Twele F; Kaczmarek E; Anjum M; Hillmann P; Löscher W
Neuropharmacology; 2020 Jan; 162():107817. PubMed ID: 31654704
[TBL] [Abstract][Full Text] [Related]
23. Agomelatine protects against neuronal damage without preventing epileptogenesis in the kainate model of temporal lobe epilepsy.
Tchekalarova J; Atanasova D; Nenchovska Z; Atanasova M; Kortenska L; Gesheva R; Lazarov N
Neurobiol Dis; 2017 Aug; 104():1-14. PubMed ID: 28438504
[TBL] [Abstract][Full Text] [Related]
24. Repeated low-dose kainate administration in C57BL/6J mice produces temporal lobe epilepsy pathology but infrequent spontaneous seizures.
Umpierre AD; Bennett IV; Nebeker LD; Newell TG; Tian BB; Thomson KE; White HS; White JA; Wilcox KS
Exp Neurol; 2016 May; 279():116-126. PubMed ID: 26896834
[TBL] [Abstract][Full Text] [Related]
25. Blood plasma inflammation markers during epileptogenesis in post-status epilepticus rat model for temporal lobe epilepsy.
Holtman L; van Vliet EA; Aronica E; Wouters D; Wadman WJ; Gorter JA
Epilepsia; 2013 Apr; 54(4):589-95. PubMed ID: 23398413
[TBL] [Abstract][Full Text] [Related]
26. Anti-epileptogenic and Anti-convulsive Effects of Fingolimod in Experimental Temporal Lobe Epilepsy.
Pitsch J; Kuehn JC; Gnatkovsky V; Müller JA; van Loo KMJ; de Curtis M; Vatter H; Schoch S; Elger CE; Becker AJ
Mol Neurobiol; 2019 Mar; 56(3):1825-1840. PubMed ID: 29934763
[TBL] [Abstract][Full Text] [Related]
27. The intrahippocampal kainate model of temporal lobe epilepsy revisited: epileptogenesis, behavioral and cognitive alterations, pharmacological response, and hippoccampal damage in epileptic rats.
Rattka M; Brandt C; Löscher W
Epilepsy Res; 2013 Feb; 103(2-3):135-52. PubMed ID: 23196211
[TBL] [Abstract][Full Text] [Related]
28. Immediate Epileptogenesis after Kainate-Induced Status Epilepticus in C57BL/6J Mice: Evidence from Long Term Continuous Video-EEG Telemetry.
Puttachary S; Sharma S; Tse K; Beamer E; Sexton A; Crutison J; Thippeswamy T
PLoS One; 2015; 10(7):e0131705. PubMed ID: 26161754
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of (immuno)proteasome subunits during epileptogenesis is attenuated by inhibition of the mammalian target of rapamycin pathway.
Broekaart DWM; van Scheppingen J; Geijtenbeek KW; Zuidberg MRJ; Anink JJ; Baayen JC; Mühlebner A; Aronica E; Gorter JA; van Vliet EA
Epilepsia; 2017 Aug; 58(8):1462-1472. PubMed ID: 28643873
[TBL] [Abstract][Full Text] [Related]
30. Hippocampal neurodegeneration, spontaneous seizures, and mossy fiber sprouting in the F344 rat model of temporal lobe epilepsy.
Rao MS; Hattiangady B; Reddy DS; Shetty AK
J Neurosci Res; 2006 May; 83(6):1088-105. PubMed ID: 16493685
[TBL] [Abstract][Full Text] [Related]
31. Disease-modifying effects of RHC80267 and JZL184 in a pilocarpine mouse model of temporal lobe epilepsy.
Ma L; Wang L; Yang F; Meng XD; Wu C; Ma H; Jiang W
CNS Neurosci Ther; 2014 Oct; 20(10):905-15. PubMed ID: 24989980
[TBL] [Abstract][Full Text] [Related]
32. Status Epilepticus Dynamics Predicts Latency to Spontaneous Seizures in the Kainic Acid Model.
Costa AM; Lucchi C; Simonini C; Rosal Lustosa Í; Biagini G
Cell Physiol Biochem; 2020 May; 54(3):493-507. PubMed ID: 32415763
[TBL] [Abstract][Full Text] [Related]
33. The systemic kainic acid rat model of temporal lobe epilepsy: Long-term EEG monitoring.
Van Nieuwenhuyse B; Raedt R; Sprengers M; Dauwe I; Gadeyne S; Carrette E; Delbeke J; Wadman WJ; Boon P; Vonck K
Brain Res; 2015 Nov; 1627():1-11. PubMed ID: 26381287
[TBL] [Abstract][Full Text] [Related]
34. Development of an antiepileptogenesis drug screening platform: Effects of everolimus and phenobarbital.
Barker-Haliski M; Knox K; Zierath D; Koneval Z; Metcalf C; Wilcox KS; White HS
Epilepsia; 2021 Jul; 62(7):1677-1688. PubMed ID: 34080183
[TBL] [Abstract][Full Text] [Related]
35. Electrophysiologic analysis of a chronic seizure model after unilateral hippocampal KA injection.
Bragin A; Engel J; Wilson CL; Vizentin E; Mathern GW
Epilepsia; 1999 Sep; 40(9):1210-21. PubMed ID: 10487183
[TBL] [Abstract][Full Text] [Related]
36. Berberine ameliorates intrahippocampal kainate-induced status epilepticus and consequent epileptogenic process in the rat: Underlying mechanisms.
Sedaghat R; Taab Y; Kiasalari Z; Afshin-Majd S; Baluchnejadmojarad T; Roghani M
Biomed Pharmacother; 2017 Mar; 87():200-208. PubMed ID: 28061403
[TBL] [Abstract][Full Text] [Related]
37. The Kinase Fyn As a Novel Intermediate in L-DOPA-Induced Dyskinesia in Parkinson's Disease.
Sanz-Blasco S; Bordone MP; Damianich A; Gomez G; Bernardi MA; Isaja L; Taravini IR; Hanger DP; Avale ME; Gershanik OS; Ferrario JE
Mol Neurobiol; 2018 Jun; 55(6):5125-5136. PubMed ID: 28840468
[TBL] [Abstract][Full Text] [Related]
38. Targeting Fyn Kinase in Alzheimer's Disease.
Nygaard HB
Biol Psychiatry; 2018 Feb; 83(4):369-376. PubMed ID: 28709498
[TBL] [Abstract][Full Text] [Related]
39. The effects of lamotrigine and ethosuximide on seizure frequency, neuronal loss, and astrogliosis in a model of temporal-lobe epilepsy.
Wang J; Chen Y; Wang Q; van Luijtelaar G; Sun M
Brain Res; 2019 Jun; 1712():1-6. PubMed ID: 30707894
[TBL] [Abstract][Full Text] [Related]
40. Disease-modifying benefit of Fyn blockade persists after washout in mouse Alzheimer's model.
Smith LM; Zhu R; Strittmatter SM
Neuropharmacology; 2018 Mar; 130():54-61. PubMed ID: 29191754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
